Search clinical trials for: marine protein hydrolysate 2134

Total 381 results

Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

COVID-19

Iran, Islamic Republic of
University of Nebraska

Completed

Effect of Enamel Matrix Proteins on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients

Periodontal Bone Loss

United States
Zimmer Biomet

Completed

Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis (PROGRESS IV)

Osteoarthritis

United States
Cale Jacobs, PhD

Terminated

IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions (EASI ACL)

Anterior Cruciate Ligament Tear

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Weill Medical College of Cornell University
Swedish Orphan Biovitrum

Withdrawn

Anakinra, COVID-19, Cytokine Storm (SOBI)

Covid19 | Mechanical Ventilation Complication | Cytokine Storm

United States
Mirati Therapeutics Inc.

Active, not recruiting

Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)

Advanced Solid Tumor

United States
Cedars-Sinai Medical Center
OneLegacy Foundation

Active, not recruiting

Berinert (C1INH) vs Placebo for DGF/IRI

Chronic Kidney Diseases | End Stage Renal Disease

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Cedars-Sinai Medical Center

Completed

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI (C1INHDGF)

End Stage Renal Disease | Ischemic Reperfusion Injury | Kidney Failure | Delayed Graft Function

United States
OncoImmune, Inc.
University of Maryland, Baltimore

Terminated

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003) (CALIBER)

HIV Infections | Dyslipidemias

United States
University of Zurich

Completed

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study

Postprandial Fatigue

Switzerland
UMC Utrecht
Prothya Biosolutions

Terminated

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture (CAESAR)

Sepsis | Inflammation | Trauma | Multiple Organ Dysfunction Syndrome

Netherlands
Helse Stavanger HF
University of Oslo; University of Stavanger

Completed

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome

Fatigue | Primary Sjogren

Norway
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole

Gastroesophageal Reflux Disease

Korea, Republic of
Steno Diabetes Center Copenhagen
Juvenile Diabetes Research Foundation; Oeresund Diabetes Academy

Completed

Anti-Interleukin-1 in Diabetes Action (AIDA)

Type 1 Diabetes

Spain, Denmark, Netherlands, Germany, Italy, Poland, Switzerland
University Hospital, Basel, Switzerland
Pharming Technologies B.V.; Clinical Trial Unit, University Hospital Basel,...

Completed

Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT)

Acute Kidney Injury

Switzerland
CSL Behring

Completed

Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

Bulgaria, United States, Poland, Spain, Hungary, United Kingdom, Russian Federation, Macedonia, The Former Yugoslav Republic of, Argentina, Australia, Canada, Czech Republic, Israel, Romania, Sweden
Eilean Therapeutics

Recruiting

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

AML

Australia
University of California, Los Angeles
Orthopedic Research and Education Foundation

Recruiting

Biologic Therapy to Prevent Osteoarthritis After ACL Injury

Anterior Cruciate Ligament Injuries

United States
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Stanford University

Terminated

Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

Pain | Inflammation

United States
Assiut University

Unknown

Haemostatic Imbalance in Patients With Chronic Liver Disease

Haemostasis Imbalance in Chronic Liver Disease
Karabuk University
Bolu Izzet Baysal Physiotherapy and Rehabilitation Training and Research...

Completed

The Relationship Between Lower Limb Functionality, Foot Joint Position Sensation and Balance in Haemiplegic Patients

Being Between 40-80 Years Old | Being Diagnosed With Haemiplegia | Getting 20 Points or More in the Mini Mental Test | Volunteering to Participate in the Study | Level 2 or Above According to Functional Ambulation Classification

Turkey
Adel Helmy
Cambridge University Hospitals NHS Foundation Trust

Unknown

IL-1ra Dose-range Study for Moderate-to-severe TBI Patients (IL1ra)

Traumatic Brain INjury

United Kingdom
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)

Covid19 Vaccine

Taiwan, Vietnam
Mansoura University

Unknown

A Randomized Controlled Trial on Wound Irrigation in Open Appendectomy.

Appendicitis

Egypt
GlaxoSmithKline

Completed

A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors

Neoplasms | Cancer

United Kingdom, France
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

Covid19 Vaccine

Taiwan
Washington University School of Medicine

Recruiting

Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer (IMPARC)

Recurrent Rectal Cancer

United States
Oslo University Hospital
University of Oslo; Lovisenberg Diakonale Hospital

Withdrawn

Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy

Knee Injuries

Norway
Lynkcell Europe

Enrolling by invitation

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Breast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA Mutation

Ukraine
Dana-Farber Cancer Institute

Completed

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Glioblastoma

United States
National Cancer Centre, Singapore

Recruiting

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Colorectal Cancer | Pancreatic Adenocarcinoma

Singapore
Novavax

Completed

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

Respiratory Syncytial Virus Infections

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (LateAna)

Asthma
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Intranasal Diagnostics in Food Allergy: a Feasibility Study (INDY)

Food Allergy

United Kingdom
University of Alabama at Birmingham

Completed

Early Treatment of Cytokine Storm Syndrome in Covid-19

COVID-19 | Cytokine Storm

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (EarlyAna)

Asthma
Leiden University Medical Center
Novartis

Recruiting

NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study) (NEO-ATACT)

Anaplastic Thyroid Cancer

Netherlands
Sidney Kimmel Comprehensive Cancer Center at Johns...
Novartis; National Comprehensive Cancer Network

Completed

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Cholangiocarcinoma | Soft-tissue Sarcoma | Solid Tumors | Thyroid Cancer

United States
Lynkcell Europe

Available

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Kidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Julie Wei, MD

Completed

Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children

Sinusitis

United States
University of Edinburgh
NHS Lothian

Completed

Long Term Nebulised Gentamicin in Patients With Bronchiectasis

Bronchiectasis

United Kingdom
Novartis Pharmaceuticals

Active, not recruiting

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

Carcinoma, Non-Small-Cell Lung

China
Novartis Pharmaceuticals

Available

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Melanoma | Adjuvant
Korea University Guro Hospital
Korean Center for Disease Control and Prevention

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Nanjing NingQi Medicine Science and Technology...

Unknown

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Non-small Cell Lung Cancer

China
Genexine, Inc.

Active, not recruiting

Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

SARS-CoV-2

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

Gastroesophageal Reflux Disease

Korea, Republic of

Search clinical trials for: marine protein hydrolysate 2134

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations